Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26116078 | 0.96 | TSHR (0.63) | TSHRTHRBALDH1A1LMNAHSD17B10 | |
| SCHEMBL27509510 | 0.86 | TSHR (0.77) | TSHRTHRBALDH1A1POLBAPEX1 | |
| SCHEMBL8849146 | 0.85 | TSHR (0.63) | TSHRTHRBALDH1A1HSD17B10POLB | |
| SCHEMBL160208 | 0.84 | TSHR (0.73) | TSHRTHRBALDH1A1POLBAPEX1 | |
| Ether SCHEMBL4969139 | 0.83 | TSHR (0.56) | TSHRTHRBALDH1A1HSD17B10TDP1 | |
| SCHEMBL16803334 | 0.83 | TSHR (0.66) | TSHRTHRBALDH1A1 | |
| SCHEMBL3343930 | 0.83 | TSHR (0.66) | TSHRTHRBALDH1A1 | |
| SCHEMBL7154371 | 0.83 | TSHR (0.66) | TSHRTHRBALDH1A1 | |
| SCHEMBL156577 | 0.83 | TSHR (0.66) | TSHRTHRBALDH1A1 | |
| SCHEMBL672401 | 0.83 | TSHR (0.66) | TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599322-B2 | Method for an analyte sensor cover-membrane preparation | ROCHE DIABETES CARE, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-3735903-B1 | METHOD FOR AN ANALYTE SENSOR COVER-MEMBRANE PREPARATION | ROCHE DIABETES CARE GMBH (DE) | 2025-11-05 | — | — | EP | disclosed |
| CN-120199683-A | Method of manufacturing semiconductor device and composition comprising floating additive | 台湾积体电路制造股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-20250197548-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2025-06-19 | — | — | US | disclosed |
| WO-2025095112-A1 | POLYMER-GRAFTED BARIUM TITANATE | 株式会社大阪ソーダ | 2025-05-08 | — | — | WO | disclosed |
| CN-119511631-A | Resist underlayer composition | 台湾积体电路制造股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| EP-4355798-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-117545785-A | Biodegradable graft polymers | 巴斯夫欧洲公司 | 2024-02-09 | — | — | CN | disclosed |
| WO-2022263354-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2022-12-22 | — | — | WO | disclosed |
| CN-114585700-A | Two-part adhesive composition comprising borane-amine complex | 波士胶公司 | 2022-06-03 | — | — | CN | disclosed |
| US-6797391-B2 | WHICH CAN GIVE PAINT FILM MANIFESTING HIGH DEGREE OF HYDROPHILIC PROPERTY, WHICH HAS A FUNCTION OF CLEANING THE STAINED AUTOMOBILE BY SELF WASHING WITH RAIN | BASF NOF COATINGS CO., LTD. (JP) | 2004-09-28 | — | — | US | disclosed |
| US-20040122128-A1 | Coating material composition for dental prosthesis | GC CORPORATION (JP) | 2004-06-24 | — | — | US | disclosed |
| EP-1430866-A1 | Coating material composition for dental prosthesis | GC Corporation (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-20030040561-A1 | Nonstaining coating compositions, method of finish coating, and coated articles | BASF JAPAN LTD. (JP) | 2003-02-27 | — | — | US | disclosed |
| CN-1397841-A | Positive film type light sensitiveness anticorrosion additive compsn. and application thereof | MITSUI CHEMICALS INC (JP) | 2003-02-19 | — | — | CN | disclosed |
| US-5700576-A | ACRYLATED ESTER POLYMERS | ROEHM GMBH CHEMISCHE FABRIK (DE) | 1997-12-23 | — | — | US | disclosed |
| EP-0465835-B1 | Anionic living polymers, their derivatives and composition comprising them | DAINIPPON INK & CHEMICALS (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5241002-A | High-solid paints, adhesives and coatings from a curable hydrolyzed acetal or ketal-containing methacrylic ester polymer and isocyanate hardener | DAINIPPON INK AND CHEMICALS, LTD. (JP) | 1993-08-31 | — | — | US | disclosed |
| US-5194547-A | Methacrylic acid ester polymer containing at least one acetal or ketal group; paints, adhesives, molding materials | DAINIPPON INK & CHEMICALS, INC. (JP) | 1993-03-16 | — | — | US | disclosed |
| EP-0465835-A1 | Anionic living polymers, their derivatives and composition comprising them | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1992-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12599322-B2 | Method for an analyte sensor cover-membrane preparation | F10, S100A10, EPCAM | TSHR 726/4885THRB 2250/4885ALDH1A1 1382/4885 |
| US-20250197548-A1 | BIODEGRADABLE GRAFT POLYMERS | PCNA, ALOX12, FASN | TSHR 4841/4885THRB 4319/4885ALDH1A1 461/4885 |
| US-20040122128-A1 | Coating material composition for dental prosthesis | PHOSPHO1, ITGA2, OR10J3 | TSHR 3287/4885THRB 1312/4885ALDH1A1 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.